Biocon Limited has informed the Exchange regarding a press release dated February 08, 2024, titled "Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr; Pre-Paid USD 200 Mn towards Debt Reduction".